María José Abud

Learn More
We analyze the patent filing strategies of foreign pharmaceutical companies in Chile distinguishing between "primary" (active ingredient) and "secondary" patents (patents on modified compounds, formulations, dosages, particular medical uses, etc.). There is prior evidence that secondary patents are used by pharmaceutical originator companies in the U.S. and(More)
ACKNOWLEDGEMENTS The researchers would like to gratefully acknowledge the individuals and organizations whose support made this research possible. First and foremost, we would like to thank our primary client contacts for all of the guidance, support, and hospitality they provided to us throughout this six month process. We are also extremely grateful to(More)
  • 1